Archive for July, 2008
House Panel Votes To Extend Health Coverage For College Students Who Take Medical Leave
The House Energy and Commerce Health Subcommittee on Wednesday by voice vote approved to extend a bill (HR 2851,
Original post by Women’s Health / Gynecology News From Medical News Today
Obama Criticizes McCain On Supreme Court Judges
Democratic presidential candidate Sen. Barack Obama (Ill.) “drew sharp contrast” with Republican presidential candidate Sen. John McCain (Ariz.) on abortion rights, equal pay for women, and family and medical leave during campaign events in New York and Virginia, the Los Angeles Times reports.
Original post by Women’s Health / Gynecology News From Medical News Today
U.N., World Bank shout For Improved Access To Family Planning On Eve Of World Population Day
The United Nations Population Fund called for more action to promote birth control, gender equality and reproductive health in recognition of World Population Day on Friday, Reuters reports. According to UNFPA, contraception can prevent 2.
Original post by Women’s Health / Gynecology News From Medical News Today
Calistoga Pharmaceuticals Initiates First Oncology Clinical Trial Of Novel PI3K Delta Inhibitor, CAL-101
Calistoga Pharmaceuticals, Inc., a company committed to developing innovative medicines for the treatment of cancer and inflammatory diseases, announced the initiation of a Phase 1 clinical trial of its lead compound, CAL-101, a small molecule phosphoinositide-3 kinase (PI3K) delta inhibitor, in patients with hematologic cancer. “We at Calistoga are very pleased to be entering our first oncology trial.
Original post by Women’s Health / Gynecology News From Medical News Today
TREDAPTIVETM (Nicotinic Acid /Laropiprant) Approved In The European Union: New Lipid-Modifying Therapy To Treat LDL-C, HDL-C And Triglycerides
Merck Sharp & Dohme (MSD) announced that TREDAPTIVE™ (nicotinic acid/laropiprant, MSD) 1 g/20 mg modified-release tablets, a new lipid-modifying therapy for patients with dyslipidemia and primary hypercholesterolemia, has been approved for marketing in the European Union (EU), Iceland and Norway. TREDAPTIVE combines nicotinic acid (niacin) and laropiprant, a novel flushing pathway inhibitor.
Original post by Women’s Health / Gynecology News From Medical News Today
TheraGenetics Licenses Intellectual Property Related To Predicting Patient Response To Antidepressant Therapy
TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced that it has completed an agreement with the Centre for
Original post by Women’s Health / Gynecology News From Medical News Today
Kronos Optimal Health Company Aims To Stop Diabetes Before It Starts
More than 54 million American adults have prediabetes, but many of those society may never have to live with diabetes and all of its health complications thanks to a new prediabetes lifestyle management course created by Kronos Optimal Health Company. It is estimated that 60 percent of prediabetics can avoid diabetes altogether with manageable lifestyle choices.
Original post by Women’s Health / Gynecology News From Medical News Today
